XRI1 Antibody

What is XRRA1 and what is its functional significance in cellular processes?

XRRA1 (X-ray radiation resistance-associated protein 1) is a protein that may play a critical role in cellular responses to X-ray radiation . Though its precise mechanism remains under investigation, research suggests it contributes to radiation resistance pathways. The protein has a predicted molecular weight of approximately 90 kDa and is expressed in various human tissues and cell lines including HepG2 (liver hepatocellular carcinoma), HL-60 (promyelocytic leukemia), and U-251 MG (brain glioma) . XRRA1 likely functions within cellular DNA damage response pathways, similar to other radiation response proteins that coordinate repair mechanisms following radiation-induced damage.

What applications are XRRA1 antibodies suitable for in research settings?

XRRA1 antibodies have demonstrated efficacy in multiple experimental applications essential for investigating protein expression and localization. Based on validated testing, these antibodies are suitable for:

• Western Blotting (WB): Effective for detecting XRRA1 protein in cell and tissue lysates with recommended dilutions of 1/1000

• Immunohistochemistry on paraffin-embedded tissues (IHC-P): Successfully used at 1/100 dilution for detecting XRRA1 in fixed tissue sections

• Cross-reactivity analysis: Validated for human and mouse samples, allowing for comparative studies across these species

Unlike some DNA repair protein antibodies that work across multiple applications including immunoprecipitation and immunofluorescence (such as XRCC1 antibodies ), XRRA1 antibodies have their specific optimal applications that researchers should consider when designing experiments.

What controls should be included when working with XRRA1 antibodies?

When designing experiments using XRRA1 antibodies, appropriate controls are essential for result validation and troubleshooting. Recommended controls include:

• Positive tissue/cell controls: HepG2, HL-60, and U-251 MG cell lines have demonstrated detectable levels of XRRA1 expression and serve as excellent positive controls

• Negative controls:

  • Primary antibody omission control

  • Isotype control (rabbit IgG at matching concentration)

  • Non-expressing tissue (if identified)

• Loading controls: For Western blotting, standard housekeeping proteins (β-actin, GAPDH, tubulin) should be used to normalize protein loading

• Molecular weight verification: The predicted band size for XRRA1 is approximately 90 kDa . Any significant deviation may indicate non-specific binding or protein modification

Including these controls will help distinguish between specific antibody binding and background signal, a critical consideration for reliable data interpretation.

How can XRRA1 antibodies be optimized for detecting radiation-induced changes in protein expression?

Detecting radiation-induced changes in XRRA1 expression requires careful experimental design and optimization. Consider these methodological approaches:

• Time-course experiments: Since radiation response proteins often show temporal expression patterns, collect samples at multiple timepoints (0h, 2h, 6h, 12h, 24h, 48h) post-irradiation to capture the complete expression profile.

• Subcellular fractionation: XRRA1 may relocalize following radiation exposure. Use nuclear, cytoplasmic, and chromatin fractionation methods before Western blotting to detect compartment-specific changes.

• Signal enhancement techniques:

  • For low abundance detection, use high-sensitivity chemiluminescent substrates

  • Consider signal amplification systems for IHC-P applications

  • Optimize antibody concentration through titration experiments (0.5-2 μg/mL range)

• Radiation dosage considerations: Create a dose-response curve (0.5-10 Gy) to determine the optimal radiation exposure for XRRA1 expression changes

Remember that radiation response proteins often function within multiprotein complexes, so their detection might be affected by protein-protein interactions or post-translational modifications following radiation exposure.

How do XRRA1 antibody applications compare with other DNA repair protein detection methods?

XRRA1 antibody applications should be considered within the broader context of DNA repair protein detection methodologies. The table below compares key aspects of XRRA1 antibody techniques with other established DNA repair protein detection methods:

When designing multiplexed experiments involving detection of multiple DNA repair proteins, consider the differential antibody performance characteristics across applications, and validate compatibility of detection systems to avoid cross-reactivity.

What methodological considerations should researchers address when investigating XRRA1 interactions with DNA repair machinery?

Investigating potential interactions between XRRA1 and established DNA repair proteins requires methodological rigor:

• Proximity ligation assays: This technique can detect protein-protein interactions in situ with high sensitivity and is particularly valuable when conventional co-IP approaches yield inconsistent results.

• Sequential ChIP (ChIP-reChIP): If XRRA1 associates with chromatin in repair complexes, sequential ChIP can identify co-localization with known repair factors such as RAD51 or RPA1A, which have established roles in homologous recombination repair (HRR) pathways .

• CRISPR-based approaches: Consider generating XRRA1-knockout cell lines to assess changes in recruitment of other repair factors (such as RAD51, RPA1A) to damaged DNA, similar to methodologies used for analyzing other repair proteins .

• DNA damage induction specificity: Different damaging agents may recruit distinct repair complexes:

  • X-ray/ionizing radiation (double-strand breaks)

  • UV radiation (pyrimidine dimers)

  • Chemical crosslinkers (interstrand crosslinks)

  • Alkylating agents (base modifications)

Each damage type might reveal different XRRA1 interaction partners, providing insights into its functional role within specific repair pathways.

What are the optimal sample preparation protocols for detecting XRRA1 in different experimental systems?

Sample preparation significantly impacts XRRA1 antibody performance. Based on validated approaches for similar radiation response proteins, consider these preparation methods:

• Western blot sample preparation:

  • Use RIPA buffer supplemented with protease inhibitors and phosphatase inhibitors

  • Include 1-5 mM NaF and 1 mM Na3VO4 to preserve phosphorylation status

  • Quick sample processing at 4°C is critical to prevent protein degradation

  • Heat samples at 95°C for 5 minutes in Laemmli buffer with reducing agent

• IHC-P tissue processing:

  • Fixation in 10% neutral-buffered formalin for 24 hours is optimal

  • Paraffin embedding should follow standard protocols

  • Consider antigen retrieval using citrate buffer (pH 6.0) or EDTA buffer (pH 9.0)

  • Blocking with 5% normal goat serum reduces background

• Cell line preparation:

  • For adherent cell lines (HepG2, U-251 MG), 70-80% confluence yields optimal results

  • For suspension cells (HL-60), harvest in log growth phase

  • Standardize cell collection and lysis protocols to ensure reproducibility

These preparation methods have been validated with XRRA1 antibody in human small intestine tissue as well as multiple cell lines, yielding consistent and specific detection .

How can researchers troubleshoot common issues when working with XRRA1 antibodies?

When encountering technical difficulties with XRRA1 antibody applications, systematic troubleshooting approaches can address common issues:

• No signal in Western blot:

  • Verify protein transfer using reversible protein stain

  • Increase antibody concentration (try 1/500 instead of 1/1000)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Use more sensitive detection reagents

  • Check if target protein is expressed in your sample (compare with positive control)

• High background in IHC-P:

  • Optimize blocking conditions (5-10% normal serum)

  • Reduce primary antibody concentration (try 1/200 instead of 1/100)

  • Extend washing steps (minimum 3x10 minutes)

  • Use biotin/avidin blocking if using biotinylated secondary antibodies

  • Consider autofluorescence quenching methods if using fluorescent detection

• Multiple bands in Western blot:

  • Verify predicted molecular weight (90 kDa for XRRA1)

  • Additional bands might represent isoforms, degradation products, or post-translational modifications

  • Use freshly prepared samples to minimize degradation

  • Include protease inhibitor cocktail during sample preparation

• Inconsistent results between experiments:

  • Standardize all protocols and reagent lots

  • Establish positive controls for each experiment

  • Document all experimental variables (antibody dilution, incubation time/temperature)

  • Consider batch processing samples for direct comparison

These troubleshooting approaches address the most common technical issues researchers encounter when working with antibodies targeting radiation response proteins.

What considerations should be made when analyzing XRRA1 in the context of other DNA repair pathways?

When investigating XRRA1 in relation to established DNA repair pathways, consider these methodological approaches:

• Pathway component analysis: Evaluate XRRA1 expression alongside key DNA repair proteins from different pathways:

  • Homologous recombination repair (HRR): RAD51, BRCA1, RPA1A

  • Base excision repair (BER): XRCC1

  • Non-homologous end joining (NHEJ): Ku70/80, DNA-PKcs

  • Single-strand break repair: PARP1, XRCC1

• Damage-specific recruitment: Different DNA damaging agents recruit specific repair mechanisms:

  • X-ray radiation primarily induces double-strand breaks and oxidative damage

  • Analyze XRRA1 recruitment alongside pathway-specific proteins using the same damage induction

• Temporal dynamics: DNA repair follows coordinated temporal patterns:

  • Early responders: γH2AX, MDC1 (minutes)

  • Intermediate factors: 53BP1, BRCA1 (30 minutes to hours)

  • Late factors: RAD51, DNA polymerases (hours)

  • Determine where XRRA1 fits in this temporal sequence

• Functional redundancy: Consider potential compensatory mechanisms:

  • Test XRRA1 expression and function in cells deficient in other repair factors

  • Evaluate expression changes of other repair proteins when XRRA1 is depleted

This integrated approach will help position XRRA1 within the complex network of DNA repair pathways and determine its functional significance in radiation response.

What emerging technologies might enhance XRRA1 antibody applications in radiation biology research?

Future investigations of XRRA1 could benefit from emerging technological approaches that extend beyond traditional antibody applications:

• Live-cell imaging technologies:

  • CRISPR-based tagging of endogenous XRRA1 with fluorescent reporters

  • FRAP (Fluorescence Recovery After Photobleaching) to study XRRA1 dynamics

  • High-content imaging platforms for quantitative analysis of XRRA1 recruitment

• Single-cell analysis methods:

  • Mass cytometry (CyTOF) for multiplexed protein detection at single-cell resolution

  • Single-cell Western blotting for heterogeneity assessment

  • Imaging mass spectrometry for spatial distribution of XRRA1 and interacting proteins

• Advanced genomic approaches:

  • CUT&RUN or CUT&Tag as alternatives to ChIP for mapping XRRA1 DNA interactions

  • Proximity labeling (BioID, APEX) to identify protein interaction networks

  • DNA damage-specific proteomics to identify XRRA1 recruitment to damaged chromatin

These technologies could overcome current limitations in antibody-based detection methods and provide more comprehensive insights into XRRA1 function in radiation response pathways.

How might XRRA1 antibody research connect to broader questions in DNA damage response research?

XRRA1 research has potential implications for several broader research areas in radiation biology:

• Cross-pathway coordination: XRRA1 might serve as a connector between different DNA repair mechanisms, similar to how various HRR factors interact with other pathways through regulatory proteins .

• Tissue-specific damage responses: Compare XRRA1 expression and function across different tissue types, particularly radiosensitive (bone marrow, intestinal epithelium) versus radioresistant tissues (brain, muscle).

• Chromatin context influence: Investigate how XRRA1 function differs between euchromatic and heterochromatic regions, similar to studies showing differential recruitment of repair factors to distinct chromatin environments .

• Systems biology approaches: Develop integrated models of radiation response incorporating XRRA1 within the broader DNA damage response network, potentially identifying new therapeutic targets or radiation protection strategies.

These research directions could position XRRA1 study within the larger framework of DNA damage response research and potentially reveal novel insights into radiation resistance mechanisms.